Growth Metrics

Nexalin Technology (NXL) Operating Income (2021 - 2026)

Nexalin Technology has reported Operating Income over the past 5 years, most recently at $4.3 million for Q4 2025.

  • For Q4 2025, Operating Income rose 247.87% year-over-year to $4.3 million; the TTM value through Dec 2025 reached -$1.7 million, up 77.74%, while the annual FY2025 figure was -$1.7 million, 77.74% up from the prior year.
  • Operating Income for Q4 2025 was $4.3 million at Nexalin Technology, up from -$2.3 million in the prior quarter.
  • Over five years, Operating Income peaked at $4.3 million in Q4 2025 and troughed at -$2.9 million in Q4 2024.
  • A 5-year average of -$1.1 million and a median of -$1.2 million in 2024 define the central range for Operating Income.
  • Biggest five-year swings in Operating Income: plummeted 723.87% in 2023 and later skyrocketed 247.87% in 2025.
  • Year by year, Operating Income stood at -$577489.0 in 2021, then dropped by 24.61% to -$719617.0 in 2022, then plummeted by 125.74% to -$1.6 million in 2023, then crashed by 77.0% to -$2.9 million in 2024, then skyrocketed by 247.87% to $4.3 million in 2025.
  • Business Quant data shows Operating Income for NXL at $4.3 million in Q4 2025, -$2.3 million in Q3 2025, and -$1.6 million in Q2 2025.